A study to investigate immune challenge induced skin reactions with SAR445399, canakinumab and spesolimab compared with placebo, in healthy participants aged 18 to 55 years
This research study is looking at how different medicines might affect skin reactions that are triggered by our immune system. It involves healthy adults aged 18 to 55. The study wants to compare three specific medicines – SAR445399, canakinumab, and spesolimab – with a 'placebo', which is a dummy treatment without any active medicine. By doing this, researchers hope to understand more about how these medicines work and how they impact the skin's response when the immune system is activated. This is a very early stage study, focusing on how these medicines behave in the human body, rather than treating a specific illness.
At a glance
What is this study about?
Our immune system is our body's defence against illness and infection. Sometimes, it can cause reactions, such as skin changes. This study is designed to explore how certain new medicines might influence these skin reactions. Researchers will give healthy volunteers different treatments, including three specific new medicines called SAR445399, canakinumab, and spesolimab, and also a dummy treatment (placebo). The main aim is to carefully observe and compare how each treatment affects the skin when the immune system is gently challenged.
This type of study is called a 'Phase I' trial. This means it's one of the first times these medications are being tested in humans. The focus is on safety and understanding how the medicines work in the body, rather than on treating a specific disease. It helps doctors learn important information about the medicines before they can be tested in larger groups of people who have particular health conditions.
The information gathered from this study could help scientists better understand how our immune system causes skin problems. This knowledge might eventually lead to new ways to help people with conditions where their immune system causes unwanted skin reactions, even though this study itself isn't for treating a disease. It's a foundational step in medical research.
Key takeaways
- This study is for healthy adults aged 18 to 55.
- It aims to understand how new medicines affect immune system skin reactions.
- You might receive one of three medicines or a 'dummy' treatment (placebo).
- It's an early-stage study focusing on safety and how medicines work.
- Your participation helps to advance medical knowledge for future treatments.
Who may be eligible?
This study is looking for healthy adult volunteers, both men and women. You must be aged between 18 and 55 years old to be considered.
The study team will need to check your general health to make sure you are suitable. This might involve looking at your medical history and doing some health checks. Being 'healthy' for this study means you don't have any significant ongoing medical conditions that could affect the results or your safety with the study medicines.
More specific details about who can and cannot take part will be provided by the study team. They will ensure it's safe for you to participate and that you meet all the necessary requirements for the research.
- Are you between 18 and 55 years old?
- Do you consider yourself generally healthy?
- Are you able to attend several clinic visits?
- Are you willing to have blood tests and other health checks?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you would receive one of the study medicines (SAR445399, canakinumab, or spesolimab) or a placebo (a dummy treatment). Your participation would involve several visits to the study clinic for health checks, receiving the medication, and having samples taken (like blood tests) to see how your body reacts. The researchers would carefully monitor any changes in your skin reaction.
The exact number and length of visits, as well as the total time you would be involved in the study, would be explained in detail by the study team. This would include follow-up appointments to ensure your well-being after receiving the treatment.
Potential risks and benefits
Locations (1)
- —Netherlands
Common questions
What does 'immune challenge' mean?
It means the researchers will gently activate your immune system in a controlled way to see how your body, particularly your skin, reacts to it.
What is a 'placebo'?
A placebo is a 'dummy' treatment that looks just like the real medicine but contains no active ingredients. It helps researchers compare the effects of the actual medicines.
Will this study treat a medical condition I have?
No, this study is for healthy volunteers and is designed to learn about the medicines, not to treat any illnesses. It's an early-stage study.
What kind of 'skin reactions' are they looking for?
The study will look for any changes in your skin, such as redness, swelling, or irritation, that might be caused by your immune system.
Will I know which medicine I'm getting?
Usually, in studies like this, you won't know if you're getting an active medicine or the placebo. This helps ensure the results are unbiased.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.